The principle and application in clinic of dynamic contrast enhancement magnetic resonance imaging

WANG Ai-bo; BIAN Jie

Journal of China Clinic Medical Imaging ›› 2016, Vol. 27 ›› Issue (6) : 435-438.

Author information +

History +

Abstract

Dynamic contrast enhancement magnetic resonance imaging(DCE-MRI) has received more and more attention in clinical and scientific work, as a new technology of MRI. This new technology makes a breakthrough of the limitation of traditional MRI which just focuses on morphologies of lesions, and analyses microscopic conditions of lesions with quantitative analysis or semi quantitative analysis and with the application of corresponding pharmacokinetics model, and provide more comprehensive diagnosis messages. With the progress of the research, DCE-MRI will make more contribution to clinical and scientific work.

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Ai-bo, BIAN Jie. The principle and application in clinic of dynamic contrast enhancement magnetic resonance imaging[J]. Journal of China Clinic Medical Imaging. 2016, 27(6): 435-438

References

[1]张薇，张龙江，黄伟. 动态对比增强MRI的基本原理及其在肝脏病变的应用[J]. 国际医学放射学杂志，2014，37（1）：41-45.
[2]Türkbey B, Thomasson D, Pang Y, et al. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment[J]. Diagn Interv Radiol, 2010, 16(3): 186-192.
[3]Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging[J]. J Magn Reson Imaging, 2003, 17(5): 509-520.
[4]Leach MO, Morgan B, Tofts PS, et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging[J]. Eur Radiol, 2012, 22(7): 1451-1464.
[5]贾中正，张军，汤伟军，等. DCE-MRI评估脑胶质瘤微血管通透性[J]. 中国医学计算机成像杂志，2013，19（4）：293-297.
[6]Paldino MJ, Barboriak DP. Fundamentals of quantitative dynamic contrast-enhanced MR imaging[J]. Mag Reson Imaging Clin North Am, 2009, 17(2): 277-289.
[7]Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues[J]. Pharmacol Rev, 1951, 3(1): 1-41.
[8]Khalifa F, Soliman A, El-Baz A, et al. Models and methods for analyzing DCE-MRI: A review[J]. Med Phys, 2014, 41(12): 124-301.
[9]Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging[J]. J Comput Assist Tomogr, 1991, 15(4): 621-628.
[10]Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data, acquisition, analysis, and examples[J]. Curr Med Imaging Rev, 2009, 3(2): 91-107.
[11]De Bruyne S, Van Damme N, Smeets P, et al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases[J]. Brit J Cancer, 2012, 106(12): 1926-1933.
[12]Bali MA, Metens T, Denolin V, et al. Tumoral and nontumoral pancreas correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters[J]. Radiology, 2011, 261(2): 456-466.
[13]赵林，何翠菊，陈莉，等. 动态增强MRI和扩散加权成像在乳腺癌新辅助化疗早期预测疗效的价值[J]. 中国肿瘤，2010，19（5）：351-354.
[14]孙静，敖炜群，耿和，等. DWI结合DCE-MRI在前列腺癌分期诊断中的应用[J]. 中国临床医学影像杂志，2014，25（12）：870-873.
[15]陈婷，张晶，张玉东，等. MR动态增强扫描对早期宫颈癌的诊断及分期价值的研究[J]. 临床放射学杂志，2014，33（9）：1376-1380.
[16]林蒙，余小多，李琳，等. MRI动态增强对鼻咽癌同步放化疗敏感性的预测研究[J]. 临床放射学杂志，2014，33（5）：689-694.
[17]Wedam SB, Low JA, Yang SX, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer[J]. J Clin Oncol, 2006, 24(5): 769-777.
[18]Gülberg V, Haag K, Rssle M, et al. Hepatic arterial buffer response in patients with advanced cirrhosis[J]. Hepatology, 2002, 35(3): 630-634.
[19]高紫红，王玉梅，于德新. DCE-MRI在评估肝硬化血流动力学与肝功能关系中的应用[J]. 放射学实践，2012，27（8）：885-888.
[20]Chen BB, Hsu CY, Yu CW, et al. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients[J]. Eur Radiol, 2012, 22(1): 171-180.
[21]Noren B, Forsgren MF, Dahlqvist Leinhard O, et al. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA[J]. Eur Radiol, 2013, 23(1): 174-181.
[22]Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography[J]. Circulation, 2001, 103(18): 2230-2235.
[23]Ibrahim T, Nekolla SG, Schreiber K, et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography[J]. J Am Coll Cardiol, 2002, 39(5): 864-870.
[24]李光，高平，刘焦枝，等. DCE-MRA在胸腹部大血管病变中的价值探讨[J]. 现代医用影像学，2006，15（4）：155-158.
[25]Laissy JP, Faraggi M, Lebtahi R, et al. Functional evaluation of normaland ischemic kidney by means of gadolinium-DOTA enhanced turbo FLASHMR imaging: a preliminary comparison with 99Tc-MAG3 dynamic scintigraphy[J]. Magn Reson Imaging, 1994, 12(3): 413-419.
[26]Shariat RI, Stacul F, Cova M, et al. Morpho-functional study of the kidney in patients with kidney disease and liver disease with magnetic resonance[J]. Radiol Med, 1998, 95(1): 72-81.
[27]冯逢，孟薇，苏颖，等. 动态增强磁共振成像对正常人肾功能的评估[J]. 中国医学影像技术，2002，18（11）：1150-1203.
[28]Frank JA, Choyke PL, Girton ME, et al. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity[J]. J Comput Assist Tomogr, 1989, 13(3): 448-459.
[29]姜新雅，仇斌，李文政，等. 颅内恶性胶质瘤术后脑组织正常反应与术后残存的动态增强MRI鉴别[J]. 中国医学影像技术，2004，2（4）：575-593.
[30]范兵，杜华睿，王霄英，等. MRI动态增强扫描定量参数对脑胶质瘤分级诊断价值的研究[J]. 放射学实践，2014，29（8）：893-895.
[31]初广宇. DCE-MRI对强直性脊柱炎骶髂关节量化评估的研究[D]. 长春：吉林大学，2015.
[32]Rahmah NN, Horiuchi T, Kusano Y, et al. Early changes in tissue perfusion after tissue plasminogen activator administration in hyperacute ischemic stroke: initial experiences with arterial spinlabeling perfusion magnetic resonance imaging[J]. Neurol Med Chir, 2013, 53(4): 213-216.
[33]李智勇，张婷婷，李梦颖，等. 动态增强磁共振成像在孤立性富血供肺结节良恶性鉴别诊断中的临床研究[J]. CT理论与应用研究，2012，21（3）：563-570.